from remdesivir to human convalescent plasma: understanding covid-19 therapeutic development
Published 4 years ago • 2.1K plays • Length 56:59Download video MP4
Download video MP3
Similar videos
-
42:48
covid-19: therapeutic update
-
17:34
top sars-cov-2 / covid-19 questions answered - july update!
-
15:12
192 - an update on covid-19 treatments: monoclonal antibodies, convalescent plasma, remdesivir...
-
12:38
convalescent plasma for covid-19
-
1:16:49
fighting covid-19 with convalescent plasma, potent antibodies, and an understanding of immunity
-
13:36
the covid-19 trials: chasing potential treatments | what to know | wtk
-
4:49
covid-19 and antibody plasma treatments
-
48:34
cdc spheres: harnessing the power of genomics to bolster our covid-19 response
-
8:04
coronavirus update 115: convalescent plasma vs monoclonal antibodies for covid 19 treatment
-
29:08
remdesivir treatment for covid-19: new drug review. veklury coronavirus antiviral from gilead.
-
1:40
remdesivir for covid-19
-
58:18
blood plasma therapies for covid-19
-
48:59
in pursuit of a vaccine for sars-cov-2 - asm virtual congressional briefing
-
9:51
convalescent plasma: recommendations for physicians treating patients with covid-19, part 1
-
50:29
covid-19 insights: convalescent plasma to treat covid-19. how does it work?
-
5:10
don't believe fda's decision to use convalescent plasma is a rushed decision: dr. scott wright
-
1:48
after plasma therapy, now remdesivir to be dropped from 'line of treatment' for covid-19 patients?
-
5:13
dr. lapook on the effectiveness of remdesivir and convalescent plasma as coronavirus treatments
-
1:27:42
learning to treat covid-19 — clinical trials and developing therapeutics during a pandemic